These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8878027

  • 21. Alpha-v-beta3 integrin expression in melanocytic nevi and cutaneous melanoma.
    Neto DS, Pantaleão L, de Sá BC, Landman G.
    J Cutan Pathol; 2007 Nov; 34(11):851-6. PubMed ID: 17944725
    [Abstract] [Full Text] [Related]

  • 22. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT, Sinowatz F, Kölle S, Takahashi H, Parsons P, Waters M.
    Anticancer Res; 1999 Nov; 19(3A):1919-31. PubMed ID: 10470136
    [Abstract] [Full Text] [Related]

  • 23. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG.
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [Abstract] [Full Text] [Related]

  • 24. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA.
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [Abstract] [Full Text] [Related]

  • 25. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.
    Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291
    [Abstract] [Full Text] [Related]

  • 26. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
    McDonnell JM, Sun YY, Wagner D.
    Ophthalmology; 1991 Apr 01; 98(4):453-8. PubMed ID: 1711186
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE, Fountaine TJ, Hennessy J, Bruggeman RD, Clarke JT, Mauger DT, Helm KF.
    J Cutan Pathol; 2009 Apr 01; 36(4):433-8. PubMed ID: 19278428
    [Abstract] [Full Text] [Related]

  • 31. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E, Mack AF, Garbe C, Klessen C.
    Br J Dermatol; 2005 Dec 01; 153(6):1159-65. PubMed ID: 16307652
    [Abstract] [Full Text] [Related]

  • 32. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May 01; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
    Li Q, Murphy M, Ross J, Sheehan C, Carlson JA.
    J Cutan Pathol; 2004 Nov 01; 31(10):633-42. PubMed ID: 15491322
    [Abstract] [Full Text] [Related]

  • 35. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins.
    Mortarini R, Gismondi A, Maggioni A, Santoni A, Herlyn M, Anichini A.
    Cancer Res; 1995 Oct 15; 55(20):4702-10. PubMed ID: 7553652
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
    Kindblom LG, Lodding P, Rosengren L, Baudier J, Haglid K.
    Acta Pathol Microbiol Immunol Scand A; 1984 Jul 15; 92(4):219-30. PubMed ID: 6496075
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 15; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 40. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB, Hakvoort TB, Swart GW, Westerhof W, Lamers WH, Das PK.
    J Pathol; 2002 Jan 15; 196(1):51-8. PubMed ID: 11748642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.